Navigation Links
Men Who at Risk Of Developing Prostate Cancer

Men who have a brother with prostate cancer are twice as likely to develop the disease themselves. A new study shows// more men realize this fact and are taking steps to prevent cancer.

A recent study done compared data from two studies, researchers asked men about their risk and, also, if they are currently taking vitamins or supplements to prevent prostate cancer.The first study shows more than half of the 111 men surveyed were concerned about developing the disease. All of the men had a brother who had been diagnosed with prostate cancer. The lifetime risk for men with a brother who has prostate cancer is about 56 percent, suggesting that the men surveyed are accurately accessing their risk.

The second study asked the same group of men about their use of complementary and alternative medicine. More than half said they were taking at least one vitamin or supplement, and 30 percent were using a type of complementary medicine linked to prostate health or prostate cancer prevention.

Thus specialist conclude that patient education programs are working and more people are able to understand the seriousness of the problem.
'"/>




Page: 1

Related medicine news :

1. Risk Of Developing Arthritis
2. Developing HIV fighter
3. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
4. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
5. Identifying The Risks Of Developing Schizophrenia
6. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
7. Cancer Patients At A Greater Risk Of Developing Blood Clots
8. Young Smokers at Increased Risk Of Developing a Heart Attack
9. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment
10. Individuals Born In May At A Higher Risk Of Developing Multiple Sclerosis
11. Risk Of Developing Infections High In Patients Who Suffer From Abdominal Trauma

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Men Who Risk Developing Prostate Cancer

(Date:11/27/2009)... SAN FRANCISCO, Nov. 27 ...d that Blair Lambert, CFO/COO, will present at the...eld at the May Fair Hotel in London, England, on W..., To listen to a live broadcast of The Gymboree C...e log on to www.gymboree.com, click on "Our Compan...
(Date:11/27/2009)...d cycling plus low-emission vehicles may reduce fu... FRIDAY, Nov. 27 (HealthDay News) -- Encouraging c...cars would offer much greater public health benefi....K. researchers have found. , The study compare...ive urban land transport scenarios for London, Eng...
(Date:11/27/2009)... Specialist manufacturers who use m...re saving millions of dollars by bringing in techn... Increasing numbers of pro-active medical manufact...the concept stage of their projects, ensuring that...gn processes or potentially outdated technology. ...
(Date:11/26/2009)...er sequestering drug tetrathiomolybdate (TM) has b...ent of Wilson disease, a disease caused by an over...at much is known. Very little, however, is known a... A new study led by Northwestern University resea...ree-dimensional structure of TM bound to copper-lo...
(Date:11/26/2009)... Research Triangle Dental (RTDental...h Carolina, today announced the expansion of its s...ER Dentist, Dr. Doug Macmillan. , ...e Dental is pleased to announce that Dr. Doug Macm...y completed an additional advanced training semina...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...ssistance in the hardest hit ...0 More than 78,000 are dead and,millions are home...alteser,International has been providing assistanc... was among the few agencies able,to provide immedi...
...m Treatment of Chronic,Idiopathic Thrombocytopenic...(NYSE: GSK ),today announced that the United Stat...dvisory Committee (ODAC) unanimously voted, 16-0, ...ytopenic purpura (ITP). The FDA advisory committee...
...erienced a 50 percent membership ... MDwise employees today are,celebrating the latest...diana managed health care plan -- surpassing the 3...t -- going from just,over 50 employees at that tim...
...Nutrition has announced the 2008 American Gastroen...Scholars. The grants have been awarded to seven ou... make significant strides in the field of gastroin... a three-year period. The goal of the Research Sch...
...n can do to,our skin -- but what about the sun,s i...t from Transitions Optical at:, http://media.media...nalists can access video, audio, text, graphics an...ricted use at http://www.mediaseed.tv ., 05NY08...
...199C of the National Union of Hospital and Healthc... ratified a four-year contract agreement with,Hahn...rcent increase in,wages and benefits., District 1...negotiations begun Wednesday morning and concluded...
Other Medicine News:Health News:More Than 78,000 are Dead and Millions are Homeless After Cyclone Nargis Swept Through Myanmar 2Health News:PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 2Health News:PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 3Health News:PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 4Health News:MDwise Enrollment Exceeds 300,000 Members 2Health News:7 outstanding young gastroenterologists receive AGA Foundation 2008 Research Scholars Award 2Health News:7 outstanding young gastroenterologists receive AGA Foundation 2008 Research Scholars Award 3Health News:7 outstanding young gastroenterologists receive AGA Foundation 2008 Research Scholars Award 4
(Date:11/27/2009)... ACUO TECHNOLOGIES, developers of h... data migration tools and services, is pleased to ...rk Office has approved a patent application for an...work." Acuo Technologies is pleased to add the U.S.... In general, the granted patent application broad...
(Date:11/25/2009)...5 American Scientific Re...s pleased to announce that they have opened a regi... Shanghai, China. ,, ASR has been able to secur...y for the development and production of current an...nd adults to be distributed and sold globally. Cu...
(Date:11/25/2009)... ERT (Nasdaq: ERES ), a...ompany,s President and CEO, and Keith Schneck, the...cheduled to present at the 21st Annual Piper Jaffr...er 1, 2009 in New York City, New York. ,, Inter...ing the Company,s corporate website at http://www...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2American Scientific Resources Inc. Opens Shanghai Location 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2ZyStor Therapeutics Inc Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 5457 1ZyStor Therapeutics Inc Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 5457 2ZyStor Therapeutics Inc Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 5457 3SEI Defined Benefit Client Recognized With Leading Plan Design Award 5454 1SEI Defined Benefit Client Recognized With Leading Plan Design Award 5454 2Shared Bed May Raise SIDS Risk 59436 1Shared Bed May Raise SIDS Risk 59436 2
...epatitis C and LymphoStat-B(R) for lupus on track ... -,- ABthrax(TM) for inhalation anthrax on track t...hened with investments in oncology portfolio and n... - GSK to advance darapladib to Phase 3 for ath...ome Sciences,Inc. (Nasdaq: HGSI ) today will repo...
... on Updated Results Showing a 20% Reduction in the...t of Disease Free Survival at Five Years, ...EWATER, N.J., May 28 Sanofi-aventis U.S.,announce... (FDA) approved,the supplemental new drug applicat...alysis from the MOSAIC trial in the Eloxatin(R) (o...
Other Medicine Technology:Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 2Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 3Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 4Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 5Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 6Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 7Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 8Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 9Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 10Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 11New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 2New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 3New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 4
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: